Get Premium to unlock powerful stock data

Endurant Capital Management LP Buys Humana Inc, Johnson & Johnson, AbbVie Inc, Sells Thermo Fisher Scientific Inc, Laboratory Corp of America Holdings, Cigna Corp

Author's Avatar
insider
Nov 16, 2021
Article's Main Image
San Mateo, CA, based Investment company Endurant Capital Management LP (Current Portfolio) buys Humana Inc, Johnson & Johnson, AbbVie Inc, SI-BONE Inc, Hologic Inc, sells Thermo Fisher Scientific Inc, Laboratory Corp of America Holdings, Cigna Corp, Haemonetics Corp, Eargo Inc during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Endurant Capital Management LP. As of 2021Q3, Endurant Capital Management LP owns 51 stocks with a total value of $382 million. These are the details of the buys and sells.

For the details of Endurant Capital Management LP's stock buys and sells, go to https://www.gurufocus.com/guru/endurant+capital+management+lp/current-portfolio/portfolio

These are the top 5 holdings of Endurant Capital Management LP
  1. S&P 500 ETF TRUST ETF (SPY) - 25,300 shares, 19.34% of the total portfolio.
  2. Trillium Therapeutics Inc (TRIL) - 206,800 shares, 9.51% of the total portfolio.
  3. AbbVie Inc (ABBV) - 180,429 shares, 5.10% of the total portfolio. Shares added by 110.99%
  4. Humana Inc (HUM) - 44,022 shares, 4.49% of the total portfolio. Shares added by 178.78%
  5. Johnson & Johnson (JNJ) - 98,077 shares, 4.15% of the total portfolio. Shares added by 197.22%
New Purchase: McKesson Corp (MCK)

Endurant Capital Management LP initiated holding in McKesson Corp. The purchase prices were between $188.42 and $208.66, with an estimated average price of $199.89. The stock is now traded at around $221.550000. The impact to a portfolio due to this purchase was 1.7%. The holding were 32,551 shares as of 2021-09-30.

New Purchase: AptarGroup Inc (ATR)

Endurant Capital Management LP initiated holding in AptarGroup Inc. The purchase prices were between $119.35 and $141.18, with an estimated average price of $131.75. The stock is now traded at around $134.840000. The impact to a portfolio due to this purchase was 1.6%. The holding were 51,191 shares as of 2021-09-30.

New Purchase: AdaptHealth Corp (AHCO)

Endurant Capital Management LP initiated holding in AdaptHealth Corp. The purchase prices were between $21.49 and $27.46, with an estimated average price of $24.23. The stock is now traded at around $25.300000. The impact to a portfolio due to this purchase was 1.19%. The holding were 194,886 shares as of 2021-09-30.

New Purchase: PerkinElmer Inc (PKI)

Endurant Capital Management LP initiated holding in PerkinElmer Inc. The purchase prices were between $151.98 and $190.5, with an estimated average price of $176.11. The stock is now traded at around $186.460000. The impact to a portfolio due to this purchase was 0.87%. The holding were 19,264 shares as of 2021-09-30.

New Purchase: Becton, Dickinson and Co (BDX)

Endurant Capital Management LP initiated holding in Becton, Dickinson and Co. The purchase prices were between $238.54 and $262.88, with an estimated average price of $251.45. The stock is now traded at around $245.100000. The impact to a portfolio due to this purchase was 0.71%. The holding were 11,077 shares as of 2021-09-30.

New Purchase: Sanofi SA (SNY)

Endurant Capital Management LP initiated holding in Sanofi SA. The purchase prices were between $47.89 and $53.12, with an estimated average price of $50.89. The stock is now traded at around $51.030000. The impact to a portfolio due to this purchase was 0.69%. The holding were 54,821 shares as of 2021-09-30.

Added: Humana Inc (HUM)

Endurant Capital Management LP added to a holding in Humana Inc by 178.78%. The purchase prices were between $389.15 and $471.22, with an estimated average price of $424.73. The stock is now traded at around $450.150000. The impact to a portfolio due to this purchase was 2.88%. The holding were 44,022 shares as of 2021-09-30.

Added: Johnson & Johnson (JNJ)

Endurant Capital Management LP added to a holding in Johnson & Johnson by 197.22%. The purchase prices were between $161.5 and $179.47, with an estimated average price of $170.65. The stock is now traded at around $162.910000. The impact to a portfolio due to this purchase was 2.75%. The holding were 98,077 shares as of 2021-09-30.

Added: AbbVie Inc (ABBV)

Endurant Capital Management LP added to a holding in AbbVie Inc by 110.99%. The purchase prices were between $106.4 and $120.78, with an estimated average price of $114.24. The stock is now traded at around $116.950000. The impact to a portfolio due to this purchase was 2.68%. The holding were 180,429 shares as of 2021-09-30.

Added: SI-BONE Inc (SIBN)

Endurant Capital Management LP added to a holding in SI-BONE Inc by 1073.49%. The purchase prices were between $19.65 and $31.89, with an estimated average price of $25.38. The stock is now traded at around $21.825000. The impact to a portfolio due to this purchase was 2.42%. The holding were 471,214 shares as of 2021-09-30.

Added: Hologic Inc (HOLX)

Endurant Capital Management LP added to a holding in Hologic Inc by 80.55%. The purchase prices were between $67.56 and $80.74, with an estimated average price of $74.96. The stock is now traded at around $73.250000. The impact to a portfolio due to this purchase was 1.73%. The holding were 200,119 shares as of 2021-09-30.

Added: Bristol-Myers Squibb Co (BMY)

Endurant Capital Management LP added to a holding in Bristol-Myers Squibb Co by 109.56%. The purchase prices were between $59.17 and $69.31, with an estimated average price of $65.87. The stock is now traded at around $59.365000. The impact to a portfolio due to this purchase was 1.71%. The holding were 211,821 shares as of 2021-09-30.

Sold Out: Thermo Fisher Scientific Inc (TMO)

Endurant Capital Management LP sold out a holding in Thermo Fisher Scientific Inc. The sale prices were between $509.53 and $609.78, with an estimated average price of $548.6.

Sold Out: Haemonetics Corp (HAE)

Endurant Capital Management LP sold out a holding in Haemonetics Corp. The sale prices were between $57.6 and $70.59, with an estimated average price of $63.18.

Sold Out: Eargo Inc (EAR)

Endurant Capital Management LP sold out a holding in Eargo Inc. The sale prices were between $6.59 and $38.71, with an estimated average price of $26.78.

Sold Out: Trillium Therapeutics Inc (TRIL)

Endurant Capital Management LP sold out a holding in Trillium Therapeutics Inc. The sale prices were between $5.86 and $17.8, with an estimated average price of $11.74.

Sold Out: Anthem Inc (ANTM)

Endurant Capital Management LP sold out a holding in Anthem Inc. The sale prices were between $357.51 and $398.13, with an estimated average price of $380.13.

Sold Out: Fate Therapeutics Inc (FATE)

Endurant Capital Management LP sold out a holding in Fate Therapeutics Inc. The sale prices were between $59.27 and $95.73, with an estimated average price of $78.58.



Here is the complete portfolio of Endurant Capital Management LP. Also check out:

1. Endurant Capital Management LP's Undervalued Stocks
2. Endurant Capital Management LP's Top Growth Companies, and
3. Endurant Capital Management LP's High Yield stocks
4. Stocks that Endurant Capital Management LP keeps buying
Rating:
NaN / 5 ( votes)
Author's Avatar
WRITTEN BY

GuruFocus Screeners

Related Articles

Q&A with Gurus